Literature DB >> 25988566

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.

René H M Raeven1,2, Larissa van der Maas1, Wichard Tilstra1, Joost P Uittenbogaard1, Tim H E Bindels1, Betsy Kuipers3, Arno van der Ark1, Jeroen L A Pennings4, Elly van Riet1, Wim Jiskoot2, Gideon F A Kersten1,2, Bernard Metz1.   

Abstract

The current resurgence of whooping cough is alarming, and improved pertussis vaccines are thought to offer a solution. Outer membrane vesicle vaccines (omvPV) are potential vaccine candidates, but omvPV-induced humoral responses have not yet been characterized in detail. The purpose of this study was to determine the antigen composition of omvPV and to elucidate the immunogenicity of the individual antigens. Quantitative proteome analysis revealed the complex composition of omvPV. The omvPV immunogenicity profile in mice was compared to those of classic whole cell vaccine (wPV), acellular vaccine (aPV), and pertussis infection. Pertussis-specific antibody levels, antibody isotypes, IgG subclasses, and antigen specificity were determined after vaccination or infection by using a combination of multiplex immunoassays, two-dimensional immunoblotting, and mass spectrometry. The vaccines and infection raised strong antibody responses, but large quantitative and qualitative differences were measured. The highest antibody levels were obtained by omvPV. All IgG subclasses (IgG1/IgG2a/IgG2b/IgG3) were elicited by omvPV and in a lower magnitude by wPV, but not by aPV (IgG1) or infection (IgG2a/b). The majority of omvPV-induced antibodies were directed against Vag8, BrkA, and LPS. The broad and balanced humoral response makes omvPV a promising pertussis vaccine candidate.

Entities:  

Keywords:  2D-electrophoresis; Bordetella pertussis; Western blot; antibody; humoral; outer membrane vesicle; proteomics; subclass; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25988566     DOI: 10.1021/acs.jproteome.5b00258

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  34 in total

Review 1.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

Review 2.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

3.  Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination.

Authors:  R Hm Raeven; J Brummelman; J L A Pennings; L van der Maas; K Helm; W Tilstra; A van der Ark; A Sloots; P van der Ley; W van Eden; W Jiskoot; E van Riet; C Acm van Els; G Fa Kersten; W Gh Han; B Metz
Journal:  Mucosal Immunol       Date:  2017-09-20       Impact factor: 7.313

4.  Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Authors:  Ang Lin; Danijela Apostolovic; Maja Jahnmatz; Frank Liang; Sebastian Ols; Teghesti Tecleab; Chenyan Wu; Marianne van Hage; Ken Solovay; Keith Rubin; Camille Locht; Rigmor Thorstensson; Marcel Thalen; Karin Loré
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 5.  Cell membrane-derived nanomaterials for biomedical applications.

Authors:  Ronnie H Fang; Yao Jiang; Jean C Fang; Liangfang Zhang
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

Review 6.  Phylogenetic Classification and Functional Review of Autotransporters.

Authors:  Kaitlin R Clarke; Lilian Hor; Akila Pilapitiya; Joen Luirink; Jason J Paxman; Begoña Heras
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

7.  Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells.

Authors:  René H M Raeven; Jolanda Brummelman; Larissa van der Maas; Wichard Tilstra; Jeroen L A Pennings; Wanda G H Han; Cécile A C M van Els; Elly van Riet; Gideon F A Kersten; Bernard Metz
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

8.  Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine.

Authors:  René H M Raeven; Jolanda Brummelman; Jeroen L A Pennings; Larissa van der Maas; Wichard Tilstra; Kina Helm; Elly van Riet; Wim Jiskoot; Cécile A C M van Els; Wanda G H Han; Gideon F A Kersten; Bernard Metz
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

9.  Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis.

Authors:  Inonge van Twillert; Axel A Bonačić Marinović; Betsy Kuipers; Jacqueline A M van Gaans-van den Brink; Elisabeth A M Sanders; Cécile A C M van Els
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

Review 10.  Roads to the development of improved pertussis vaccines paved by immunology.

Authors:  Jolanda Brummelman; Mieszko M Wilk; Wanda G H Han; Cécile A C M van Els; Kingston H G Mills
Journal:  Pathog Dis       Date:  2015-09-06       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.